ID

14361

Descripción

Efficacy and Tolerability of Beclometasone/Formoterol Single Inhaler in Patients With Moderate to Severe Persistent Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00476268

Link

https://clinicaltrials.gov/show/NCT00476268

Palabras clave

Versiones (1)
  1. 12/4/16 12/4/16 -
Titular de derechos de autor

CC BY-NC 3.0

Subido en

12 de abril de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Asthma NCT00476268

Inglés

Eligibility Asthma NCT00476268

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00476268
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
clinical diagnosis of moderate to severe persistent asthma (according to gina 2002 guidelines)
Descripción

moderate to severe persistent asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1960047
UMLS CUI [2]
C1960048
fev1 > 40% and < 80% of predicted normal post-bronchodilator (and at least 0.7 l absolute value)
Descripción

post-bronchodilator fev1

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C2599594
patients already treated for at least 2 months with an association of inhaled corticosteroids plus laba at doses of:
Descripción

inhaled corticosteroids plus laba

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2065041
UMLS CUI [2]
C1373132
750 - 1000 µg beclomethasone dipropionate or equivalent (icss) 24 µg formoterol or 100 µg salmeterol (labas)
Descripción

beclomethasone dipropionate formoterol salmeterol

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004906
UMLS CUI [2]
C0060657
UMLS CUI [3]
C0073992
or patients naïve of laba already treated for at least 2 months with inhaled corticosteroids (doses as above) associated with a daily use of saba and/or with clinical symptoms > 3 times in the week prior to inclusion
Descripción

naive of laba inhaled corticosteroids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2]
C2065041
a documented positive response to the reversibility test.
Descripción

reversibility test

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1272658
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or lactating females or women of childbearing potential without any efficient contraception.
Descripción

pregnancy or lactation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3]
C3831118
UMLS CUI [4,1]
C0700589
UMLS CUI [4,2]
C0332197
heavy smokers defined as smoking for > 10 pack years.
Descripción

smoking history

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1519384
UMLS CUI [1,2]
C1277691
evidence of asthma exacerbation causing an hospitalisation or requiring treatment with oral/parenteral corticosteroids or evidence of symptomatic airways infection in the 4 weeks prior to inclusion (3 months for slow-release corticosteroids).
Descripción

asthma exacerbation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0349790
UMLS CUI [1,2]
C0040223
UMLS CUI [2]
C4039704
UMLS CUI [3]
C0019993
UMLS CUI [4,1]
C0035243
UMLS CUI [4,2]
C0040223
seasonal asthma or asthma occurring only during episodic exposure to an allergen or occupational chemical sensitizer.
Descripción

seasonal asthma or allergic asthma

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2919352
UMLS CUI [2]
C0155877
clinically significant or unstable concomitant diseases, including clinically significant laboratory abnormalities.
Descripción

comorbidity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
patients with an abnormal qtc interval value in the ecg test, defined as > 450 msec in males or > 470 msec in females.
Descripción

qtc interval

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0489625
evidence of asthma worsening during the week preceding randomisation (e.g. pef variability > 30% during 2 consecutive days, saba use > 8 puffs/day during 2 consecutive days, nocturnal awakenings due to asthma symptoms during 3 consecutive days
Descripción

asthma worsening

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0004096
UMLS CUI [1,2]
C1457868
Volver a la parte superior de la página

Similar models

Eligibility Asthma NCT00476268

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00476268
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
moderate to severe persistent asthma
Item
clinical diagnosis of moderate to severe persistent asthma (according to gina 2002 guidelines)
boolean
C1960047 (UMLS CUI [1])
C1960048 (UMLS CUI [2])
post-bronchodilator fev1
Item
fev1 > 40% and < 80% of predicted normal post-bronchodilator (and at least 0.7 l absolute value)
boolean
C0748133 (UMLS CUI [1,1])
C2599594 (UMLS CUI [1,2])
inhaled corticosteroids plus laba
Item
patients already treated for at least 2 months with an association of inhaled corticosteroids plus laba at doses of:
boolean
C2065041 (UMLS CUI [1])
C1373132 (UMLS CUI [2])
beclomethasone dipropionate formoterol salmeterol
Item
750 - 1000 µg beclomethasone dipropionate or equivalent (icss) 24 µg formoterol or 100 µg salmeterol (labas)
boolean
C0004906 (UMLS CUI [1])
C0060657 (UMLS CUI [2])
C0073992 (UMLS CUI [3])
naive of laba inhaled corticosteroids
Item
or patients naïve of laba already treated for at least 2 months with inhaled corticosteroids (doses as above) associated with a daily use of saba and/or with clinical symptoms > 3 times in the week prior to inclusion
boolean
C0919936 (UMLS CUI [1])
C2065041 (UMLS CUI [2])
reversibility test
Item
a documented positive response to the reversibility test.
boolean
C1272658 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy or lactation
Item
pregnant or lactating females or women of childbearing potential without any efficient contraception.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3])
C0700589 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
smoking history
Item
heavy smokers defined as smoking for > 10 pack years.
boolean
C1519384 (UMLS CUI [1,1])
C1277691 (UMLS CUI [1,2])
asthma exacerbation
Item
evidence of asthma exacerbation causing an hospitalisation or requiring treatment with oral/parenteral corticosteroids or evidence of symptomatic airways infection in the 4 weeks prior to inclusion (3 months for slow-release corticosteroids).
boolean
C0349790 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
C4039704 (UMLS CUI [2])
C0019993 (UMLS CUI [3])
C0035243 (UMLS CUI [4,1])
C0040223 (UMLS CUI [4,2])
seasonal asthma or allergic asthma
Item
seasonal asthma or asthma occurring only during episodic exposure to an allergen or occupational chemical sensitizer.
boolean
C2919352 (UMLS CUI [1])
C0155877 (UMLS CUI [2])
comorbidity
Item
clinically significant or unstable concomitant diseases, including clinically significant laboratory abnormalities.
boolean
C0009488 (UMLS CUI [1])
qtc interval
Item
patients with an abnormal qtc interval value in the ecg test, defined as > 450 msec in males or > 470 msec in females.
boolean
C0489625 (UMLS CUI [1])
asthma worsening
Item
evidence of asthma worsening during the week preceding randomisation (e.g. pef variability > 30% during 2 consecutive days, saba use > 8 puffs/day during 2 consecutive days, nocturnal awakenings due to asthma symptoms during 3 consecutive days
boolean
C0004096 (UMLS CUI [1,1])
C1457868 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial